GlassScriptPhysician profile
Darren P Hee
NPI 1902864663
$1,046.17
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $220 · 2021: $364 · 2022: $27.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $197.86 | 2019-2021 | |
| Abbvie INC. | $171.16 | 2021-2022 | |
| Glaxosmithkline, LLC. | $111.28 | 2019-2021 | |
| Allergan, INC. | $103.43 | 2019-2020 | |
| Amgen INC. | $81.13 | 2019-2021 | |
| Novo Nordisk INC | $71.07 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $54.06 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.79 | 2019-2020 | |
| Sanofi Pasteur INC. | $26.66 | 2019-2020 | |
| Amarin Pharma, INC. | $24.07 | 2020 | |
| Merck Sharp & Dohme LLC | $22.81 | 2019 | |
| Corcept Therapeutics | $20.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.34 | 2019 | |
| Astellas Pharma US INC | $14.33 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.57 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.39 | 2021 | |
| Strongbridge US INC. | $11.93 | 2019 | |
| Abbott Laboratories | $11.86 | 2019 | |
| Fidia Pharma USA INC. | $5.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Hee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.